Investment
Features
FeesSafety
Academy
More
Pluang+

Compare First Trust NASDAQ 100 Technology Index Fund (QTEC) vs Tempus AI (TEM) Price & Performance

First Trust NASDAQ 100 Technology Index FundTrade

Price performance (Past 24H)

Key statistics

First Trust NASDAQ 100 Technology Index Fund vs Tempus AI — how do they compare? First Trust NASDAQ 100 Technology Index Fund trades at $306.13, while Tempus AI trades at $47.13 (market cap $8.80B). The key difference: First Trust NASDAQ 100 Technology Index Fund is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals.

QTECTEM
Sector
Broad Market / FactorBroad Market / Factor
52-Week High
$335.74$103.25
52-Week Low
$207.03$42.37
Market Cap
$8.80B
Enterprise Value
$9.47B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

First Trust NASDAQ 100 Technology Index Fund

QTEC, the First Trust NASDAQ-100-Technology Sector ETF, trades at $301.50, up 0.53% on the day. The technical outlook is bearish, with moving averages signaling a downtrend and key support at $285. Recent news highlights its role as a smart beta ETF providing broad technology sector exposure since its 2006 launch, though some reports question if recent large sales signal caution around overheated AI and chip stocks.

The ETF's outlook is clouded by bearish technicals and sector concentration risks, but its equal-weighted access to top tech firms offers targeted exposure. Key risks include market volatility and sector-specific headwinds, while the neutral oscillator readings suggest potential for stabilization near current levels.

Tempus AI

Tempus AI (TEM) trades at $48.41, down 7.74% amid market reaction to its $1.5 billion acquisition of Personalis. The stock shows bearish technical signals with negative moving averages and oversold RSI levels. Fundamentally, the company maintains strong revenue growth ($1.27B in 2025) but faces significant losses (-$245M net income) and negative margins. Recent news highlights strategic expansion in cancer diagnostics through AI-driven platforms.

Despite analyst optimism (61.5% buy ratings, $68.50 target), TEM faces execution risks from the major acquisition and persistent profitability challenges. The stock's current discount to target offers potential upside if integration succeeds, but high cash burn and competitive pressures require careful monitoring for investors considering entry at these levels.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About First Trust NASDAQ 100 Technology Index Fund

QTEC is an ETF that seeks to track the performance of the NASDAQ-100 Technology Sector Index. The fund provides targeted exposure to companies within the NASDAQ-100 that are classified as technology or telecommunications companies, focusing on firms involved in software, hardware, and related services. QTEC is a tool for investors seeking focused exposure to high-growth, large-cap technology companies listed on the NASDAQ exchange.

Read more on QTEC

About Tempus AI

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Read more on TEM